Casipong, Dionisio J.
HRN: 21-33-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/23/2022
05/30/2022
IV
4.5g
Q8
Infected Wound
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes